BSE Live
Oct 31, 16:01Prev. Close
50.11
Open Price
51.51
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Key Financial Ratios of Pharmaids Pharmaceuticals (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | -2.06 | -2.18 | -5.86 | 0.14 | 0.09 | |
| Diluted EPS (Rs.) | -2.06 | -2.18 | -5.86 | 0.14 | 0.09 | |
| Cash EPS (Rs.) | -2.01 | -1.35 | -3.52 | 0.15 | 0.13 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 18.09 | 20.15 | 10.46 | 8.44 | 8.30 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 18.09 | 20.15 | 10.46 | 8.44 | 8.30 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 0.66 | 0.01 | 0.00 | 3.84 | 8.33 | |
| PBDIT/Share (Rs.) | -1.77 | -1.58 | -4.61 | 0.15 | 0.13 | |
| PBIT/Share (Rs.) | -1.83 | -1.63 | -4.62 | 0.14 | 0.09 | |
| PBT/Share (Rs.) | -2.43 | -1.73 | -4.62 | 0.14 | 0.09 | |
| Net Profit/Share (Rs.) | -2.06 | -1.40 | -3.52 | 0.14 | 0.09 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | -266.49 | -20,057.91 | 0.00 | 3.86 | 1.55 | |
| PBIT Margin (%) | -275.01 | -20,695.32 | 0.00 | 3.63 | 1.03 | |
| PBT Margin (%) | -366.82 | -21,894.60 | 0.00 | 3.56 | 1.03 | |
| Net Profit Margin (%) | -310.95 | -17,805.03 | 0.00 | 3.68 | 1.09 | |
| Return on Networth / Equity (%) | -11.41 | -6.96 | -33.69 | 1.67 | 1.09 | |
| Return on Capital Employed (%) | -6.22 | -6.85 | -44.16 | 1.64 | 1.03 | |
| Return on Assets (%) | -6.13 | -5.82 | -30.77 | 1.30 | 1.02 | |
| Total Debt/Equity (X) | 0.62 | 0.18 | 0.00 | 0.00 | 0.00 | |
| Asset Turnover Ratio (%) | 0.02 | 0.00 | 0.00 | 0.39 | 93.81 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 0.83 | 4.31 | 8.22 | 1.09 | 1.46 | |
| Quick Ratio (X) | 0.19 | 4.11 | 8.22 | 0.73 | 0.83 | |
| Inventory Turnover Ratio (X) | 0.47 | 0.00 | 0.00 | 0.00 | 23.17 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 281.11 | 193.43 | 34.01 | 12.44 | 11.28 | |
| EV/Net Operating Revenue (X) | 120.09 | 6,958.03 | 0.00 | 3.16 | 1.32 | |
| EV/EBITDA (X) | -45.06 | -34.69 | -3.44 | 81.73 | 84.65 | |
| MarketCap/Net Operating Revenue (X) | 103.46 | 6,596.85 | 0.00 | 3.26 | 1.34 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 3.80 | 2.58 | 2.09 | 1.48 | 1.35 | |
| Price/Net Operating Revenue | 103.57 | 7,428.57 | 0.00 | 3.26 | 1.34 | |
| Earnings Yield | -0.03 | -0.03 | -0.16 | 0.01 | 0.01 | 
22.08.2025
Pharmaids Pharm Standalone June 2025 Net Sales at Rs 1.12 crore, up 569.85% Y-o-Y
27.05.2025
Pharmaids Pharm Standalone March 2025 Net Sales at Rs 0.13 crore, up 1792.86% Y-o-Y
04.03.2025
Pharmaids Pharm Consolidated December 2024 Net Sales at Rs 4.71 crore, up 22595.42% Y-o-Y
23.05.2022
Pharmaids Pharm Standalone March 2022 Net Sales at Rs 0.30 crore, down 83.95% Y-o-Y